PTC Therapeutics Inc
DUS:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PTC Therapeutics Inc
DUS:BH3
|
US |
|
T
|
Toyota Industries Corp
XMUN:TAH
|
JP |
|
Phunware Inc
F:2RJA
|
US |
|
M
|
Merck & Co Inc
XBER:6MK
|
US |
|
A
|
Anglo American Platinum Ltd
JSE:AMS
|
ZA |
|
E
|
Endeavour Silver Corp
XHAM:EJD
|
CA |
|
O
|
Origin Bancorp Inc
F:36Z
|
US |
|
Gold Fields Ltd
LSE:0IYR
|
ZA |
|
Z
|
Zions Bancorporation NA
NASDAQ:ZION
|
US |
|
E
|
Expeditors International of Washington Inc
XHAM:EW1
|
US |
|
Y
|
Ypsomed Holding AG
XBER:OWX
|
CH |
|
J
|
J M Smucker Co
XMUN:JM2
|
US |
|
T
|
Trane Technologies PLC
SWB:2IS
|
IE |
|
R
|
Rigel Pharmaceuticals Inc
SWB:RI2A
|
US |
|
Novartis AG
F:NOT
|
CH |
|
I
|
Industrial and Commercial Bank of China Ltd
XMUN:ICK
|
CN |
|
ArcelorMittal SA
NYSE:MT
|
LU |
|
K
|
Kroger Co
XMUN:KOG
|
US |
|
A
|
Aflac Inc
XMUN:AFL
|
US |
|
H
|
Hikari Tsushin Inc
OTC:HKTGF
|
JP |
Bankruptcy Probability
PTC Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PTC Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
6.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
461.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PTC Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PTC Therapeutics Inc has total debt of 2B USD. This includes both short-term (0 USD) and long-term (2B USD) debt.
You can find a full breakdown on its Balance Sheet.
